Clinical trials recruiting for Synucleinopathies
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Donanemab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 1 |
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| Florida | 1 |
| Indiana | 1 |
| Kansas | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| Missouri | 1 |
| New York | 1 |
Top cities
Self-screener
Recruiting trials
- A Comprehensive, Multimodal Characterization of Prodromal PD in Subjects With RBD
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
- Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
- Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
- Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
- Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD
- The Swedish BioFINDER Sleep Study
Related conditions
Trials recruiting for Synucleinopathies often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Synucleinopathies trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.